Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-8-14
pubmed:abstractText
In order to improve the leishmanicidal activity of the synthetic cecropin A-melittin hybrid peptide CA(1-7)M(2-9) (KWKLFKKIGAVLKVL-NH(2)), a systematic study of its acylation with saturated linear fatty acids was carried out. Acylation of the N(epsilon)-7 lysine residue led to a drastic decrease in leishmanicidal activity, whereas acylation at lysine 1, in either the alpha or the epsilon NH(2) group, increased up to 3 times the activity of the peptide against promastigotes and increased up to 15 times the activity of the peptide against amastigotes. Leishmanicidal activity increased with the length of the fatty acid chain, reaching a maximum for the lauroyl analogue (12 carbons). According to the fast kinetics, dissipation of membrane potential, and parasite membrane permeability to the nucleic acid binding probe SYTOX green, the lethal mechanism was directly related to plasma membrane permeabilization.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10066791, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10100125, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10223949, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10333735, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10353835, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10357851, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10377520, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10390200, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10446384, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10513726, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10564270, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10584003, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10590303, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10611297, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10660589, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10931439, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-10942757, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-11071264, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-11111088, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-11145218, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-11257025, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-1493807, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-1733777, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-1985886, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-2108218, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-2228243, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-2689223, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-3773734, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-6579533, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-6745388, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-7403880, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-7934902, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-8076647, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-8192470, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-8601432, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-8985641, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9166783, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9174409, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9298965, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9352466, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9353715, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9421307, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9461543, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9487696, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9580315, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9727863, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9813304, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9838145, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502512-9852202
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2441-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide.
pubmed:affiliation
Centro de Investigaciones Biológicas (CSIC), Velázquez 144, 28006 Madrid, Spain.
pubmed:publicationType
Journal Article
More...